|
Volumn 256, Issue 5, 2012, Pages
|
A survival analysis of the liver-first reversed management of advanced simultaneous colorectal liver metastases: a LiverMetSurvey-based study.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CAMPTOTHECIN;
DRUG DERIVATIVE;
IRINOTECAN;
OXALIPLATIN;
PLATINUM COMPLEX;
ARTICLE;
CHI SQUARE DISTRIBUTION;
COLORECTAL TUMOR;
COMPARATIVE STUDY;
FEMALE;
HUMAN;
LIVER TUMOR;
MALE;
METASTASIS;
MIDDLE AGED;
MULTIMODALITY CANCER THERAPY;
PATHOLOGY;
PROPENSITY SCORE;
PROPORTIONAL HAZARDS MODEL;
REGISTER;
RETROSPECTIVE STUDY;
STATISTICAL MODEL;
SURVIVAL;
TREATMENT OUTCOME;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CAMPTOTHECIN;
CHI-SQUARE DISTRIBUTION;
COLORECTAL NEOPLASMS;
COMBINED MODALITY THERAPY;
FEMALE;
HUMANS;
LIVER NEOPLASMS;
LOGISTIC MODELS;
MALE;
MIDDLE AGED;
ORGANOPLATINUM COMPOUNDS;
PROPENSITY SCORE;
PROPORTIONAL HAZARDS MODELS;
REGISTRIES;
RETROSPECTIVE STUDIES;
SURVIVAL ANALYSIS;
TREATMENT OUTCOME;
|
EID: 84872008421
PISSN: None
EISSN: 15281140
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (88)
|
References (0)
|